UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clinical and Metabolic Effects of Alpha-Lipoic Acid Associated with Two Different Doses of Myo-Inositol in Women with Polycystic Ovary Syndrome

International journal of endocrinology, 2020, Vol.2020 (2020), p.1-8

2020

Volltextzugriff (PDF)

Estetrol: A New Choice for Contraception

Journal of clinical medicine, 2021-11, Vol.10 (23), p.5625

2021

Volltextzugriff (PDF)

NOMAC-E2 compares to LNG combined oral contraceptives in women over forty: real-world PRO-E2 study

Gynecological endocrinology, 2023-12, Vol.39 (1), p.2166032-2166032

2023

Volltextzugriff (PDF)

NOMAC-E2 shows a better contraceptive effectiveness than LNG combined oral contraceptives in women under 25: real-world PRO-E2 study

Gynecological endocrinology, 2023-12, Vol.39 (1), p.2162036-2162036

2023

Volltextzugriff (PDF)

Increased anti-Mullerian hormone levels and ovarian size in a subgroup of women with functional hypothalamic amenorrhea: further identification of the link between polycystic ovary syndrome and functional hypothalamic amenorrhea

American journal of obstetrics and gynecology, 2016-06, Vol.214 (6), p.714.e1-714.e6

2016

Volltextzugriff (PDF)

A review of the pharmacology, clinical outcomes, and real-world effectiveness, safety, and non-contraceptive effects of NOMAC/E2

European journal of obstetrics & gynecology and reproductive biology: X, 2024-03, Vol.21, p.100283-100283, Article 100283

2024

Volltextzugriff (PDF)

Ovarian volume in normal and hyperandrogenic adolescent women

Fertility and sterility, 2015-07, Vol.104 (1), p.196-199

2015

Volltextzugriff (PDF)

Characterization of a novel mutation V136L in bone morphogenetic protein 15 identified in a woman affected by POI

Journal of ovarian research, 2021-06, Vol.14 (1), p.85-85, Article 85

2021

Volltextzugriff (PDF)

Insulin resistance and hyperandrogenism have no substantive association with birth weight in adolescents with polycystic ovary syndrome

Fertility and sterility, 2015-03, Vol.103 (3), p.808-814

2015

Volltextzugriff (PDF)

Hormonal Contraception and Depression: Updated Evidence and Implications in Clinical Practice

Clinical drug investigation, 2020-12, Vol.40 (12), p.1097-1106

2020

Volltextzugriff (PDF)

Adolescent girls with polycystic ovary syndrome showing different phenotypes have a different metabolic profile associated with increasing androgen levels

Fertility and sterility, 2009-08, Vol.92 (2), p.626-634

2009

Volltextzugriff (PDF)

Comparison of effects of 3 mg drospirenone plus 20 μg ethinyl estradiol alone or combined with metformin or cyproterone acetate on classic metabolic cardiovascular risk factors in nonobese women with polycystic ovary syndrome

Fertility and sterility, 2010-10, Vol.94 (5), p.1793-1798

2010

Volltextzugriff (PDF)

The use of combined hormonal contraceptives amid the COVID-19 pandemic. Reply

The European journal of contraception & reproductive health care, 2021-02, Vol.26 (1), p.87-88

2021

Volltextzugriff (PDF)

Estro-progestin Contraceptives and Risk of Cervical Cancer: A Debated Issue

Anticancer research, 2020-11, Vol.40 (11), p.5995-6002

2020

Volltextzugriff (PDF)

Oestrogens in oral contraception: considerations for tailoring prescription to women's needs

The European journal of contraception & reproductive health care, 2024-06, Vol.29 (3), p.93-102

2024

Volltextzugriff (PDF)

Comparison of two insulin sensitizers, metformin and myo-inositol, in women with polycystic ovary syndrome (PCOS)

Gynecological endocrinology, 2017-01, Vol.33 (1), p.39-42

2017

Volltextzugriff (PDF)

AMH MEASUREMENT VERSUS OVARIAN ULTRASOUND IN THE DIAGNOSIS OF POLYCYSTIC OVARY SYNDROME IN DIFFERENT PHENOTYPES

Endocrine practice, 2016-03, Vol.22 (3), p.287

2016

Volltextzugriff (PDF)

Long-term treatment with α-lipoic acid and myo-inositol positively affects clinical and metabolic features of polycystic ovary syndrome

Gynecological endocrinology, 2020-02, Vol.36 (2), p.152-155

2020

Volltextzugriff (PDF)

Pill, depression and suicide: a never-ending story of myth and reality

The European journal of contraception & reproductive health care, 2020-05, Vol.25 (3), p.240-242

2020

Volltextzugriff (PDF)

Treatment with d-chiro-inositol and alpha lipoic acid in the management of polycystic ovary syndrome

Gynecological endocrinology, 2019-06, Vol.35 (6), p.506-510

2019

Volltextzugriff (PDF)

Is the multinational, surveillance PRO-E2 study informative for all countries? The Italian data on VTE and contraceptive effectiveness

The European journal of contraception & reproductive health care, 2024-02, Vol.29 (1), p.1-7

2024

Volltextzugriff (PDF)

COVID-19, gender and estroprogestins, what do we know?

The European journal of contraception & reproductive health care, 2022-02, Vol.27 (1), p.67-74

2022

Volltextzugriff (PDF)

Venous thrombosis and hormonal contraception: what's new with estradiol-based hormonal contraceptives?

Open access journal of contraception, 2018-01, Vol.9, p.75-79

2018

Volltextzugriff (PDF)

How often is oral contraception used for contraception? The need of benefit's formalisation

The European journal of contraception & reproductive health care, 2023-04, Vol.28 (2), p.81-82

2023

Volltextzugriff (PDF)

Features of polycystic ovary syndrome (PCOS) in women with functional hypothalamic amenorrhea (FHA) may be reversible with recovery of menstrual function

Gynecological endocrinology, 2018-04, Vol.34 (4), p.301-304

2018

Volltextzugriff (PDF)

1 – 25 von 85

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(76)
Mit Volltextzugriff
(59)

Publikationsform

Sprache

Englisch
(81)
Italienisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Clinical and Metabolic Effects of Alpha-Lipoic Acid Associated with Two Different Doses of Myo-Inositol in Women with Polycystic Ovary Syndrome

Estetrol: A New Choice for Contraception

NOMAC-E2 compares to LNG combined oral contraceptives in women over forty: real-world PRO-E2 study

NOMAC-E2 shows a better contraceptive effectiveness than LNG combined oral contraceptives in women under 25: real-world PRO-E2 study

Increased anti-Mullerian hormone levels and ovarian size in a subgroup of women with functional hypothalamic amenorrhea: further identification of the link between polycystic ovary syndrome and functional hypothalamic amenorrhea

A review of the pharmacology, clinical outcomes, and real-world effectiveness, safety, and non-contraceptive effects of NOMAC/E2

Ovarian volume in normal and hyperandrogenic adolescent women

Characterization of a novel mutation V136L in bone morphogenetic protein 15 identified in a woman affected by POI

Insulin resistance and hyperandrogenism have no substantive association with birth weight in adolescents with polycystic ovary syndrome

Hormonal Contraception and Depression: Updated Evidence and Implications in Clinical Practice

Adolescent girls with polycystic ovary syndrome showing different phenotypes have a different metabolic profile associated with increasing androgen levels

Comparison of effects of 3 mg drospirenone plus 20 μg ethinyl estradiol alone or combined with metformin or cyproterone acetate on classic metabolic cardiovascular risk factors in nonobese women with polycystic ovary syndrome

The use of combined hormonal contraceptives amid the COVID-19 pandemic. Reply

Estro-progestin Contraceptives and Risk of Cervical Cancer: A Debated Issue

Oestrogens in oral contraception: considerations for tailoring prescription to women's needs

Comparison of two insulin sensitizers, metformin and myo-inositol, in women with polycystic ovary syndrome (PCOS)

AMH MEASUREMENT VERSUS OVARIAN ULTRASOUND IN THE DIAGNOSIS OF POLYCYSTIC OVARY SYNDROME IN DIFFERENT PHENOTYPES

Long-term treatment with α-lipoic acid and myo-inositol positively affects clinical and metabolic features of polycystic ovary syndrome

Pill, depression and suicide: a never-ending story of myth and reality

Treatment with d-chiro-inositol and alpha lipoic acid in the management of polycystic ovary syndrome

Is the multinational, surveillance PRO-E2 study informative for all countries? The Italian data on VTE and contraceptive effectiveness

COVID-19, gender and estroprogestins, what do we know?

Venous thrombosis and hormonal contraception: what's new with estradiol-based hormonal contraceptives?

How often is oral contraception used for contraception? The need of benefit's formalisation

Features of polycystic ovary syndrome (PCOS) in women with functional hypothalamic amenorrhea (FHA) may be reversible with recovery of menstrual function

Suchergebnisse filtern